Characteristics of expedited programmes for cancer drug approval in China
Nat Rev Drug Discov
.
2021 Jun;20(6):416.
doi: 10.1038/d41573-021-00080-0.
Authors
Guanqiao Li
,
Yang Liu
,
Cuicui Xie
,
Qing Zhou
,
Xiaoyuan Chen
PMID:
33972774
DOI:
10.1038/d41573-021-00080-0
No abstract available
MeSH terms
Antineoplastic Agents / therapeutic use*
China
Drug Approval / statistics & numerical data*
Government Agencies / trends*
Humans
Neoplasms / drug therapy*
Substances
Antineoplastic Agents